Medicine
Doxorubicin 50 mg/25 mL liposomal injection
Doxorubicin 50 mg/25 mL liposomal injection is a generic prescription medicine for intravenous use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
The following individually cartoned vials are available: Table 14 mg in vial…
Key facts
- Active ingredient (INN)
- Doxorubicin
- Brand
- Sold under the generic name
- Strength
- 50 mg/25 mL
- Dosage form
- Liposomal injection
- Route
- Intravenous
- Packs
- 1 vial of 25 mL and 3 more
- Manufacturers
- Zydus LifesciencesIndiaSun Pharmaceutical IndustriesIndiaBluePoint LaboratoriesNorthStar RxLLC
- Origin register
- US FDA, United States
- Storage
- The following individually cartoned vials are available: Table 14 mg in vial fill volume vial size NDC #s 20 mg vial 10 mL 10 mL 72603-103-01 50 mg vial 25 mL 30 mL 72603-200-01 Refrigerate unopened vials of doxorubicin hydrochloride liposome injection at 2° to 8°C (36° to 46°F). Do not freeze.
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L01DB01 Doxorubicin
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 February 2013
- Identifiers
- RxCUI 1790115, 1790127DailyMed set ID ddf55319-bf62-4ec7-8be2-ef97188837c4, f6508535-e7a7-4e50-8d0c-43deda8d0d08, ada390ce-50ea-4de5-be58-5b03caf33c23 +3NDC 72603-200, 68001-493, 68001-704 +3Application ANDA203263, ANDA212299
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 vial, single-dose in 1 carton / 25 mL in 1 vial, single-dose | 49315-009-07 | Zydus LifesciencesIndia | 14 September 2020 |
| 1 vial, single-dose in 1 carton / 25 mL in 1 vial, single-dose | 70710-1531-1 | Zydus LifesciencesIndia | 14 September 2020 |
| 1 vial, single-dose in 1 package / 25 mL in 1 vial, single-dose | 47335-050-40 | Sun Pharmaceutical IndustriesIndia | 5 February 2013 |
| 1 vial, single-dose in 1 package / 25 mL in 1 vial, single-dose | 68001-493-26 | BluePoint Laboratories | 31 May 2021 |
| 1 vial, single-dose in 1 carton / 25 mL in 1 vial, single-dose | 68001-704-26 | BluePoint Laboratories | 2 April 2026 |
| 1 vial, single-dose in 1 package / 25 mL in 1 vial, single-dose | 72603-200-01 | NorthStar RxLLC | 29 May 2019 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Doxorubicin
Clinical summary
Doxorubicin is an anthracycline topoisomerase inhibitor indicated as a component of multi-agent adjuvant chemotherapy for treatment of women with axillary lymph node involvement following resection of primary breast cancer, among other approved uses. MedsAcross supplies Doxorubicin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about DoxorubicinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Doxorubicin Hydrochloride prescribing information (Pfizer Laboratories) · U.S. National Library of Medicine, DailyMed
- Caelyx pegylated liposomal: European public assessment report (EPAR) · European Medicines Agency
- Myocet liposomal (previously Myocet): European public assessment report (EPAR) · European Medicines Agency
Need Doxorubicin 50 mg/25 mL liposomal injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.